augmentin for oral suspension 457 mg5 ml
glaxosmithkline pte ltd - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin; potassium clavulanate 67.9mg/5ml eqv clavulanic acid - powder, for suspension - 400 mg/5 ml - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin 400 mg/5 ml; potassium clavulanate 67.9mg/5ml eqv clavulanic acid 57 mg/5 ml
avandamet
smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).
avandia
smithkline beecham plc - rosiglitazone - diabetes mellitus, type 2 - drugs used in diabetes - rosiglitazone is indicated in the treatment of type 2 diabetes mellitus:as monotherapy-in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intoleranceas dual oral therapy in combination with-metformin, in patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin-a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite monotherapy with a sulphonylureaas triple oral therapy in combination with-metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy (see section 4.4).
avaglim
smithkline beecham ltd - rosiglitazone, glimepiride - diabetes mellitus, type 2 - drugs used in diabetes - avaglim is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance.
beechams cold & flu hot blackcurrant
beecham group plc - phenylephrine hydrochloride 10 mg, paracetamol 600 mg - powder for oral solution
beechams cold & flu hot lemon
beecham group plc - phenylephrine hydrochloride 10 mg, paracetamol 600 mg - powder for oral solution
beechams cold and flu hot blackcurrant powder for oral solution n/a
glaxosmithkline consumer health-care uk trading limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - phenylephrine hydrochloride, paracetamol - powder for oral solution - phenylephrine hydrochloride 10 mg paracetamol 600 mg - analgesics
beechams cold and flu hot lemon powder for oral solution
glaxosmithkline consumer health-care uk trading limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - phenylephrine, paracetamol - powder for oral solution - phenylephrine 10 mg paracetamol 600 mg - analgesics
beechams flu-plus hot lemon
beecham group plc - phenylephrine 10 mg, ascorbic acid 40 mg, paracetamol 1000 mg - powder for oral solution
augmentin for oral suspension 228 mg5 ml
glaxosmithkline pte ltd - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin; potassium clavulanate 33.95mg/5ml eqv clavulanic acid - powder, for suspension - 200 mg/5 ml - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin 200 mg/5 ml; potassium clavulanate 33.95mg/5ml eqv clavulanic acid 28.5 mg/5 ml